会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Granular composition for ruminant
    • 反刍动物颗粒组成
    • US4948589A
    • 1990-08-14
    • US293783
    • 1989-01-05
    • Hitoshi IijimaMasayuki KiuchiMasahiro NakaoKunio NishimuraShigeaki Sato
    • Hitoshi IijimaMasayuki KiuchiMasahiro NakaoKunio NishimuraShigeaki Sato
    • A23K50/10A23K20/174A23K40/10A61K9/16A61K31/14
    • A61K9/1617A23K20/174A23K40/10A23K40/35
    • A granular composition for a ruminant containing as a main component choline or a physiologically acceptable derivative thereof, wherein the composition is prepared by (1) granulating the choline or it derivative having an average particle size of 100 .mu.m or less and a maximum particle size of 150 .mu.m or less, an excipient having an average particle size of 10 .mu.m or less and a maximum particle size of 20 .mu.m or less, and a hydrophobic binder under a relative humidity of 10% or less by using an agitation granulator, followed by cooling, separating and classifying the resultant granules to obtain spherical granules having a particle size of 0.5 to 2.5 mm and (ii) forming a thin film on the surface of the granules at a temperature of at least 5.degree. C. less than a melting point of the binder and 5.degree. C. to 25.degree. C. less than a melting point of the overcoating agent under a relative humidity of 30% or less in an agitation granulator by adding 20 to 40 parts by weight, based on 100 parts by weight of the granules, of a heated molten mixture of a hydrophobic overcoating agent and a solubility modifier in the form of a fine powder in a weight ratio of 1:0.2-1.
    • 一种含有作为主要成分胆碱或其生理学上可接受的衍生物的反刍动物的粒状组合物,其中,所述组合物通过(1)将平均粒径为100μm以下的胆碱或其衍生物或最大粒径 150μm以下的平均粒径为10μm以下,最大粒径为20μm以下的赋形剂和相对湿度为10%以下的疏水性粘合剂,使用搅拌造粒机 然后冷却,分离和分级得到的颗粒,得到粒度为0.5至2.5mm的球形颗粒,和(ii)在至少5℃的温度下在颗粒表面上形成薄膜,小于 在搅拌造粒机中,相对湿度为30%以下的外敷剂的熔点低于5℃〜25℃,加入20〜40重量份,基于100 pa 颗粒重量,疏水性外涂剂的加热熔融混合物和重量比为1:0.2-1的细粉末形式的溶解度调节剂。
    • 2. 发明授权
    • 2-O- (β-D-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it
    • 2-O-(&bgr--D-吡喃葡萄糖基)抗坏血酸,其生产方法,以及含有组合物的组合物的食品和化妆品
    • US08017587B2
    • 2011-09-13
    • US11898121
    • 2007-09-10
    • Mitsuru MaedaMasahiro NakaoHarukazu Fukami
    • Mitsuru MaedaMasahiro NakaoHarukazu Fukami
    • A01N43/04A01N43/08
    • A61K8/676A23L33/105A23L33/15A23V2002/00A61K8/602A61K31/375A61K2800/52A61Q17/04A61Q19/00A61Q19/02C07H1/08C07H17/04C12P19/60A23V2250/708
    • The present invention provides a novel ascorbic acid derivative as a provitamin C with improved stability in the body and prolonged life in the body compared to conventionally known 2-O-(α-D-glucopyranosyl)ascorbic acid.The composition comprising the novel compound 2-O-(β-D-glucopyranosyl)ascorbic acid has been extracted from plants such as from Ningxia Lycium barbarum L. and/or Lycium chinense Mill. The compositions comprising 2-O-(β-D-glucopyranosyl)ascorbic acid may be enzymatically synthesized using β-D-glucosyltransferase. Pure 2-O-(β-D-glucopyranosyl)ascorbic acid may be produced from such compositions. Alternatively, 2-O-(β-D-glucopyranosyl)ascorbic acid may be produced by chemical synthesis. The 2-O-(β-D-glucopyranosyl)ascorbic acid results in higher stability and a prolonged life of vitamin C when ingested in the body compared to the corresponding α-D-glucopyranosyl derivative, and is therefore highly suitable as a provitamin C to be used in cosmetics and foods.
    • 与常规已知的2-O-(α-D-吡喃葡萄糖基)抗坏血酸相比,本发明提供了一种新型抗坏血酸衍生物作为维生素C,具有改善体内的稳定性和延长的身体寿命。 从宁夏枸杞子和/或枸杞子植物提取含有新化合物2-O-(&bgr-D-吡喃葡萄糖基)抗坏血酸的组合物。 可以使用β-葡萄糖基转移酶酶法合成包含2-O-(β-谷氨酰-D-吡喃葡萄糖基)抗坏血酸的组合物。 可以从这样的组合物制备纯2-O-(&bgr-D-吡喃葡萄糖基)抗坏血酸。 或者,可通过化学合成制备2-O-(&bgr-D-吡喃葡萄糖基)抗坏血酸。 与对应的α-D-吡喃葡萄糖基衍生物相比,2-O-(&bgr-D-吡喃葡萄糖基)抗坏血酸在身体摄取时导致更高的稳定性和更长的维生素C的使用寿命,因此非常适合作为维生素 C用于化妆品和食品。
    • 8. 发明授权
    • Lipase
    • 脂肪酶
    • US08207320B2
    • 2012-06-26
    • US12981929
    • 2010-12-30
    • Masahiro NakaoMasaki KanamoriHarukazu FukamiHiroaki KasaiMisa Ochiai
    • Masahiro NakaoMasaki KanamoriHarukazu FukamiHiroaki KasaiMisa Ochiai
    • C07H21/02C12N1/20C12N15/00
    • C12N9/20C12P7/6409C12P7/6436C12R1/01
    • The present invention provides a novel lipase with a molecular weight of about 32 kDa, which is produced by a strain belonging to the genus Tetrasphaera, as well as a gene encoding the same. This lipase has the ability to recognize a medium-chain fatty acid as a substrate. The present invention also provides a novel lipase with a molecular weight of about 40 kDa, which is produced by a strain belonging to the genus Tetrasphaera and has the ability to recognize both a medium-chain fatty acid and a long-chain fatty acid as substrates, as well as a polynucleotide encoding the same. The present invention further provides Tetrasphaera sp. strain NITE P-154. The lipase of the present invention can be used as an immobilized enzyme and is useful in fields such as production of digestants and/or flavorings, production of clinical laboratory reagents, detergent enzymes and/or fats, as well as production of optically active intermediates for agricultural chemicals and pharmaceutical preparations.
    • 本发明提供了一种分子量约32kDa的新型脂肪酶,其由属于四联属属的菌株产生,以及编码该脂肪酶的基因。 该脂肪酶具有识别中链脂肪酸作为底物的能力。 本发明还提供了一种分子量约40kDa的新型脂肪酶,其由属于四味子属的菌株产生,并且具有将中链脂肪酸和长链脂肪酸同时识别为底物的能力 ,以及编码该多核苷酸的多核苷酸。 本发明进一步提供了Tetrasphaera sp。 菌株NITE P-154。 本发明的脂肪酶可以用作固定化酶,可用于生产消化剂和/或调味剂,生产临床实验室试剂,洗涤剂酶和/或脂肪等领域,以及生产光学活性中间体 农药和药物制剂。
    • 9. 发明授权
    • 2-O-(β-D-glucopyranosyl) ascorbic acid, process for its production, and foods cosmetics containing compositions comprising it
    • 2-O-(&bgr-D-吡喃葡萄糖基)抗坏血酸,其生产方法,以及含有组合物的食品化妆品
    • US07943583B2
    • 2011-05-17
    • US11501074
    • 2006-08-09
    • Mitsuru MaedaMasahiro NakaoHarukazu Fukami
    • Mitsuru MaedaMasahiro NakaoHarukazu Fukami
    • A01N43/04A01N43/06
    • A61K8/676A23L33/105A23L33/15A23V2002/00A61K8/602A61K31/375A61K2800/52A61Q17/04A61Q19/00A61Q19/02C07H1/08C07H17/04C12P19/60A23V2250/708
    • The present invention provides a novel ascorbic acid derivative as a provitamin C with improved stability in the body and prolonged life in the body compared to conventionally known 2-O-(β-D-glucopyranosyl)ascorbic acid. The composition comprising the novel compound 2-O- (β-D-glucopyranosyl)ascorbic acid has been extracted from plants such as from Ningxia Lycium barbarum L. and/or Lycium chinense Mill. The compositions comprising 2-O-(βD-glucopyranosyl) ascorbic acid may be enzymatically synthesized using β-D-glucosyltransferase. Pure 2-O-(β-D-glucopyranosyl)ascorbic acid may be produced from such compositions. Alternatively, 2-O-(β-D-glucopyranosyl)ascorbic acid may be produced by chemical synthesis. The 2-O-(β-D-glucopyranosyl)ascorbic acid results in higher stability and a prolonged life of vitamin C when ingested in the body compared to the corresponding α-D-glucopyranosyl derivative, and is therefore highly suitable as a provitamin C to be used in cosmetics and foods.
    • 本发明提供了一种新颖的抗坏血酸衍生物作为前维生素C,与常规已知的2-O-(β-葡萄糖-D-吡喃葡萄糖基)抗坏血酸相比,体内的稳定性和体内寿命延长。 含有新化合物2-O-(&bgr-D-吡喃葡萄糖基)抗坏血酸的组合物已经从宁夏枸杞子和/或枸杞子等植物中提取出来。 包含2-O-(β-葡萄糖吡喃糖基)抗坏血酸的组合物可以使用β-葡糖基转移酶酶促合成。 可以从这样的组合物制备纯2-O-(&bgr-D-吡喃葡萄糖基)抗坏血酸。 或者,可通过化学合成制备2-O-(&bgr-D-吡喃葡萄糖基)抗坏血酸。 与对应的α-D-吡喃葡萄糖基衍生物相比,2-O-(&bgr-D-吡喃葡萄糖基)抗坏血酸在身体摄取时导致更高的稳定性和更长的维生素C的使用寿命,因此非常适合作为维生素 C用于化妆品和食品。